MSD Animal Health, a division of Merck & Co., announced on May 24 the presentation of 19 abstracts at the 14th European Symposium of Porcine Health Management (ESPHM), highlighting new research across the company s broad swine portfolio, including its intradermal vaccine, PORCILIS® Lawsonia ID.